Owners, management and financials
CVR: 41183144
Previous names: CanNordic A/S
DKK -398,874
Gross profit
Net result: DKK -461,281
CS MEDICA a/s (100%)
CVR · view owners
Lone Henriksen
Board: 3 members
CVR · view management
Active
Founded 7 February 2020
CVR · view overview
1 employee
CVR · 2023
Name registered: Galaxa Pharma a/s
CVR · 16/04/2021
View the full event history
Galaxa Pharma a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named CanNordic A/S. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -398,874 and a net result of DKK -461,281 compared with DKK -819,815 the year before. Equity in the 2025 report amounted to DKK -209,574.
Selskabets formål er at drive medicinalvirksomhed og hermed forbundne aktiviteter
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/10/2024 – 30/09/2025 | - | -461 t. | 1.4 mio. | -210 t. | 1 | |
| 202401/10/2023 – 30/09/2024 | - | -820 t. | 1.6 mio. | 252 t. | 1 | |
| 202301/10/2022 – 30/09/2023 | - | -1.7 mio. | 2.6 mio. | 572 t. | 1 | |
| 202201/10/2021 – 30/09/2022 | - | -2 mio. | 3.1 mio. | 814 t. | 2 | |
| 202101/10/2020 – 30/09/2021 | 666 t. | -134 t. | 3.4 mio. | 360 t. | 1 |
Compared to 404 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Galaxa Pharma a/s is 41183144.
Galaxa Pharma a/s is owned by CS MEDICA a/s.
The management of Galaxa Pharma a/s consists of Lone Henriksen.
The board of Galaxa Pharma a/s consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen.
In 2025, Galaxa Pharma a/s reported a gross profit of DKK -398,874.
Galaxa Pharma a/s had 1 employee in 2023 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 27742280, new email: [email protected] (April 17, 2026).
Galaxa Pharma a/s has published its annual report for 2025. Gross profit came to DKK -398,874, and the net result was DKK -461,281.
As of April 1, 2026, Jens Jørgen Hagelskjær has joined the board of directors of Galaxa Pharma a/s.
As of April 10, 2025, Mads Verner Jørgensen has left the board of directors of Galaxa Pharma a/s.
Galaxa Pharma a/s has published its annual report for 2024. Gross profit came to DKK -898,059, and the net result was DKK -819,815.
As of March 28, 2025, Lone Henriksen has joined the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Mads Verner Jørgensen has joined the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Flemming Heegaard has left the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Ib Madsen has left the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Anders Permin has left the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Jesper Herold Halle has left the board of directors of Galaxa Pharma a/s.
Galaxa Pharma a/s has published its annual report for 2023. Gross profit came to DKK -1,971,399, and the net result was DKK -1,742,863.
As of April 9, 2024, Flemming Heegaard has joined the board of directors of Galaxa Pharma a/s.
As of April 9, 2024, Ib Madsen has joined the board of directors of Galaxa Pharma a/s.
As of April 9, 2024, Jesper Herold Halle has joined the board of directors of Galaxa Pharma a/s.
As of April 9, 2024, Jørgen Flemming Ladefoged has left the board of directors of Galaxa Pharma a/s.
As of September 20, 2023, Karsten Adelmark has left the board of directors of Galaxa Pharma a/s.
As of June 30, 2023, Karsten Adelmark has joined the board of directors of Galaxa Pharma a/s.
As of June 30, 2023, Alexandre Fevre has left the board of directors of Galaxa Pharma a/s.
Galaxa Pharma a/s has published its annual report for 2022. Gross profit came to DKK -845,553, and the net result was DKK -2,045,843.
As of February 14, 2023, Stein Arve Løkstad has left the board of directors of Galaxa Pharma a/s.
As of October 25, 2022, Bo Erik Lennart Unéus has left the board of directors of Galaxa Pharma a/s.
As of February 9, 2022, Alexandre Fevre has joined the board of directors of Galaxa Pharma a/s.
Galaxa Pharma a/s has published its annual report for 2021. Revenue came to DKK 666,300, and the net result was DKK -133,658.
As of July 1, 2021, Gitte Henriksen has joined the board of directors of Galaxa Pharma a/s.
As of July 1, 2021, Jørgen Flemming Ladefoged has joined the board of directors of Galaxa Pharma a/s.
As of June 30, 2021, Gitte Henriksen has left the board of directors of Galaxa Pharma a/s.
As of June 30, 2021, Jørgen Flemming Ladefoged has left the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Jørgen Flemming Ladefoged has joined the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Anders Permin has joined the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Stein Arve Løkstad has joined the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Bo Erik Lennart Unéus has joined the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Lone Henriksen has left the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Simon Tønners has left the board of directors of Galaxa Pharma a/s.
On April 16, 2021, the company changed its name from CanNordic A/S to Galaxa Pharma a/s.
Galaxa Pharma a/s has published its interim report for the period February 7, 2020 to September 30, 2020.
As of February 7, 2020, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Galaxa Pharma a/s.
As of February 7, 2020, Lone Henriksen has joined the board of directors of Galaxa Pharma a/s.
As of February 7, 2020, Gitte Henriksen has joined the board of directors of Galaxa Pharma a/s.
As of February 7, 2020, Simon Tønners has joined the board of directors of Galaxa Pharma a/s.
As of February 7, 2020, Lone Henriksen is registered as adm. dir. of Galaxa Pharma a/s.
As of February 7, 2020, CS MEDICA a/s is registered as an owner of Galaxa Pharma a/s with an ownership share of 100%.
Galaxa Pharma a/s was founded on February 7, 2020.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 19835081
CVR 46788176
CVR 45929698
CVR 46098765
CVR 46098773
